Lynnette Marcar

903 total citations
12 papers, 664 citations indexed

About

Lynnette Marcar is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Lynnette Marcar has authored 12 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Oncology and 4 papers in Immunology. Recurrent topics in Lynnette Marcar's work include Cancer-related Molecular Pathways (5 papers), Immunotherapy and Immune Responses (3 papers) and Ubiquitin and proteasome pathways (3 papers). Lynnette Marcar is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), Immunotherapy and Immune Responses (3 papers) and Ubiquitin and proteasome pathways (3 papers). Lynnette Marcar collaborates with scholars based in United Kingdom, United States and Ireland. Lynnette Marcar's co-authors include David W. Meek, Ted R. Hupp, Nicola J. MacLaine, Diane Milne, Frances V. Fuller-Pace, Qi Liu, Henning Willers, Neil Kernohan, Mark K. Saville and Neil D. Perkins and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Lynnette Marcar

12 papers receiving 661 citations

Peers

Lynnette Marcar
Andreas Enns Germany
Daniel S. Kong United States
Heath A. Smith United States
Ivy X. Chen United States
Eman L. Dadashian United States
Vincenza Carafa Switzerland
Andreas Enns Germany
Lynnette Marcar
Citations per year, relative to Lynnette Marcar Lynnette Marcar (= 1×) peers Andreas Enns

Countries citing papers authored by Lynnette Marcar

Since Specialization
Citations

This map shows the geographic impact of Lynnette Marcar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynnette Marcar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynnette Marcar more than expected).

Fields of papers citing papers by Lynnette Marcar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynnette Marcar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynnette Marcar. The network helps show where Lynnette Marcar may publish in the future.

Co-authorship network of co-authors of Lynnette Marcar

This figure shows the co-authorship network connecting the top 25 collaborators of Lynnette Marcar. A scholar is included among the top collaborators of Lynnette Marcar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynnette Marcar. Lynnette Marcar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Grabrucker, Andreas M., et al.. (2023). Identification of Nanoparticle Properties for Optimal Drug Delivery across a Physiological Cell Barrier. Pharmaceutics. 15(1). 200–200. 10 indexed citations
2.
Marcar, Lynnette, et al.. (2021). The effect of serum starvation on tight junctional proteins and barrier formation in Caco-2 cells. Biochemistry and Biophysics Reports. 27. 101096–101096. 11 indexed citations
3.
Marcar, Lynnette, David Power, Michael A. Moloney, et al.. (2019). The Presence of a High Peak Feature Within Low-Average Shear Stimuli Induces Quiescence in Venous Endothelial Cells. Annals of Biomedical Engineering. 48(2). 582–594. 5 indexed citations
4.
Marcar, Lynnette, Kankana Bardhan, Liliana Gheorghiu, et al.. (2019). Acquired Resistance of EGFR-Mutated Lung Cancer to Tyrosine Kinase Inhibitor Treatment Promotes PARP Inhibitor Sensitivity. Cell Reports. 27(12). 3422–3432.e4. 49 indexed citations
5.
Liu, Qi, Liliana Gheorghiu, Michael Drumm, et al.. (2018). PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53. Oncogene. 37(21). 2793–2805. 48 indexed citations
6.
Han, Jing, Lynnette Marcar, Joshua C. Black, et al.. (2017). Radiation Resistance in KRAS-Mutated Lung Cancer Is Enabled by Stem-like Properties Mediated by an Osteopontin–EGFR Pathway. Cancer Research. 77(8). 2018–2028. 77 indexed citations
7.
Marcar, Lynnette, John M Hourihan, Susan E. Bray, et al.. (2015). MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4. PLoS ONE. 10(5). e0127713–e0127713. 38 indexed citations
8.
Meek, David W. & Lynnette Marcar. (2012). MAGE-A antigens as targets in tumour therapy. Cancer Letters. 324(2). 126–132. 73 indexed citations
9.
Marcar, Lynnette, Nicola J. MacLaine, Ted R. Hupp, & David W. Meek. (2010). Mage-A Cancer/Testis Antigens Inhibit p53 Function by Blocking Its Interaction with Chromatin. Cancer Research. 70(24). 10362–10370. 127 indexed citations
10.
Marcar, Lynnette, et al.. (2010). p53-dependent repression of polo-like kinase-1 (PLK1). Cell Cycle. 9(20). 4200–4212. 98 indexed citations
11.
Nicol, Samantha M., Nerea Allende-Vega, Lynnette Marcar, et al.. (2009). FKBP25, a novel regulator of the p53 pathway, induces the degradation of MDM2 and activation of p53. FEBS Letters. 583(4). 621–626. 57 indexed citations
12.
Marcar, Lynnette, Diane Milne, Mark K. Saville, et al.. (2008). Elevated Levels of Oncogenic Protein Kinase Pim-1 Induce the p53 Pathway in Cultured Cells and Correlate with Increased Mdm2 in Mantle Cell Lymphoma. Journal of Biological Chemistry. 283(26). 18012–18023. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026